Cancer rates dropped in the U.S. for the fourth straight year. Even bigger news: Two-third of cancers may be preventable.
The real news in the report was that two-third of cancers may be preventable. That number divides about equally between cancers due to smoking (the overwhelming cause of lung cancer) and cancers linked to obesity and lack of exercise (linked to cancer of the uterus, colon, kidney, pancreas, and breast cancer in post-menopausal women). Only the remaining one-third are linked to genetic mutations from all other causes, including toxins, radiation, environmental influences, etc.
A vaccine that can train cancer patients’ own bodies to seek out and destroy tumor cells has been developed by scientists.
The therapy, which targets a molecule found in 90 per cent of all cancers, could provide a universal injection that allows patients’ immune systems to fight off common cancers including breast and prostate cancer.
Preliminary results from early clinical trials have shown the vaccine can trigger an immune response in patients and reduce levels of disease
High School Student Devises Possible Cure for Cancer
Born to Chinese immigrants, 17-year-old Angela Zhang of Cupertino, California is a typical American teenager. She’s really into shoes and is just learning how to drive.
But there is one thing that separates her from every other student at Monta Vista High School, something she first shared with her chemistry teacher, Kavita Gupta.
It’s a research paper Angela wrote in her spare time — and it is advanced, to say the least. Gupta says all she knows is its recipe — for curing cancer.
Researchers have devised a protein “switch” that instructs cancer cells to produce their own anti-cancer medication.
The researchers, led by Marc Ostermeier, a Johns Hopkins chemical and biomolecular engineering professor in the Whiting School of Engineering, showed that these switches, working from inside the cells, can activate a powerful cell-killing drug when the device detects a marker linked to cancer. The goal, the scientists said, is to deploy a new type of weapon that causes cancer cells to self-destruct while sparing healthy tissue.
Promising results raise hope for cancer breakthrough: T cells could be tweaked to kill a range of cancers.
In a potential breakthrough in cancer research, scientists at the University of Pennsylvania have genetically engineered patients’ T cells — a type of white blood cell — to attack cancer cells in advanced cases of a common type of leukemia.
Two of the three patients who received doses of the designer T cells in a clinical trial have remained cancer-free for more than a year, the researchers said.
Cancer Death Rates Continue to Fall
Steady overall declines in cancer death rates have meant about 898,000 who would have died prematurely from cancer in the past 17 years did not, the organization said.
Lots more funding for young scientists exploring radical new directions in cancer research.
The “war on cancer” has been going on for decades, yet victory is still nowhere in sight. Andy Rachleff, a venture capitalist turned philanthropist, is trying to speed things up by funding research by young scientists with new ideas.